Investing.com - Incyte (NASDAQ:INCY) reported on Tuesday fourth quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Incyte announced earnings per share of $0.1 on revenue of $862.85M. Analysts polled by Investing.com anticipated EPS of $0.5678 on revenue of $813.38M.
Incyte shares are up 2% from the beginning of the year and are trading at $73.35 , down-from-52-week-high.They are outperforming the Nasdaq which is down 10.41% from the start of the year.
Incyte follows other major Healthcare sector earnings this month
Incyte's report follows an earnings beat by UnitedHealth on January 19, who reported EPS of $4.48 on revenue of $73.74B, compared to forecasts EPS of $4.3 on revenue of $72.98B.
J&J had beat expectations on January 25 with fourth quarter EPS of $2.13 on revenue of $24.8B, compared to forecast for EPS of $2.12 on revenue of $25.28B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar